Recent advance of fluorescent probes for detection of drug-induced liver injury markers

被引:21
|
作者
Sun, Dongqin [1 ]
Chen, Zhenzhen [1 ]
Hu, Jiali [1 ]
Zeng, Huajin [1 ]
Qu, Lingbo [2 ]
Yang, Ran [2 ]
机构
[1] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
[2] Zhengzhou Univ, Coll Chem, Zhengzhou 450001, Peoples R China
基金
中国国家自然科学基金;
关键词
Fluorescent probe; Drug-induced liver injury (DILI); Roussel uclaf causality assessment method (RUCAM); Clinical markers; Imaging; GLUTATHIONE-S-TRANSFERASE; IMAGING ENDOGENOUS PEROXYNITRITE; HIGHLY SELECTIVE DETECTION; ALANINE AMINOTRANSFERASE; INDUCED HEPATOTOXICITY; ENDOPLASMIC-RETICULUM; BIOLUMINESCENT PROBE; CAUSALITY ASSESSMENT; HYPOCHLOROUS ACID; ADVERSE REACTIONS;
D O I
10.1016/j.cclet.2021.12.043
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug-induced liver injury (DILI) is a common and serious adverse drug reaction. At present, DILI is perfectly diagnozed in clinical settings using Roussel Uclaf causality assessment method (RUCAM) in its original version published 1993 and its updated version published 2016, well established worldwide as a diagnostic algorithm with a high sensitivity and specificity. Nevertheless, the search for additional detection methods supporting RUCAM continues. In recent years, with the development of optical imaging technology, fluorescent probes have gradually shown great advantages in the detection and diagnosis of DILI markers such as high sensitivity, anti-interference, real-time monitoring and non-invasive measurement. In this review, the recent advances of fluorescent probes for evaluation of DILI in experimental studies were summarized according to various markers of DILI. We believe that learning about the design and practical application of these probes will contribute to the further development of detection sensors for DILI markers. (C) 2022 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页码:4478 / 4494
页数:17
相关论文
共 50 条
  • [1] Emerging fluorescent probes for bioimaging of drug-induced liver injury biomarkers: Recent advances
    Jiang, Qingqing
    Chen, Ran
    Li, Meng
    Zhang, Tianyu
    Kong, Ziyuzhu
    Ma, Kaifu
    Ye, Chao
    Sun, Xiaohan
    Shu, Wei
    BIOORGANIC CHEMISTRY, 2025, 159
  • [2] Drug-induced liver injury: a summary of recent advances
    Stine, Jonathan G.
    Lewis, James H.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (07) : 875 - 890
  • [3] Chemical probes for drug-induced liver injury imaging
    Jiang, Tao
    Rong, Pengfei
    Wang, Wei
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 835 - 852
  • [4] Drug-induced liver injury: recent advances in diagnosis and risk assessment
    Kullak-Ublick, Gerd A.
    Andrade, Raul J.
    Merz, Michael
    End, Peter
    Benesic, Andreas
    Gerbes, Alexander L.
    Aithal, Guruprasad P.
    GUT, 2017, 66 (06) : 1154 - 1164
  • [5] Design Strategy of Fluorescent Probes for Live Drug-Induced Acute Liver Injury Imaging
    Cheng, Dan
    Xu, Wang
    Gong, Xiangyang
    Yuan, Lin
    Zhang, Xiao-Bing
    ACCOUNTS OF CHEMICAL RESEARCH, 2021, 54 (02) : 403 - 415
  • [6] Recent status of drug-induced liver injury
    Takikawa, Hajime
    HEPATOLOGY RESEARCH, 2009, 39 (01) : 1 - 6
  • [7] Drug Rechallenge Following Drug-Induced Liver Injury
    Hunt, Christine M.
    Papay, Julie I.
    Stanulovic, Vid
    Regev, Arie
    HEPATOLOGY, 2017, 66 (02) : 646 - 654
  • [8] Drug-induced liver injury: a safety review
    Garcia-Cortes, Miren
    Ortega-Alonso, Aida
    Lucena, M. Isabel
    Andrade, Raul J.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) : 795 - 804
  • [9] Drug-induced liver injury in the Australian setting
    Sistanizad, M.
    Peterson, G. M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (02) : 115 - 120
  • [10] Recent advances in the diagnosis of drug-induced liver injury
    Ahmed, Taqwa
    Ahmad, Jawad
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (02) : 186 - 192